Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity

Most clinically used anticancer mAbs are of the IgG isotype, which can eliminate tumor cells through NK cell–mediated antibody-dependent cellular cytotoxicity and macrophage-mediated antibody-dependent phagocytosis. IgG, however, ineffectively recruits neutrophils as effector cells. IgA mAbs induce...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Invest
Autors principals: Heemskerk, Niels, Gruijs, Mandy, Temming, A. Robin, Heineke, Marieke H., Gout, Dennis Y., Hellingman, Tessa, Tuk, Cornelis W., Winter, Paula J., Lissenberg-Thunnissen, Suzanne, Bentlage, Arthur E.H., de Donatis, Marco, Bögels, Marijn, Rösner, Thies, Valerius, Thomas, Bakema, Jantine E., Vidarsson, Gestur, van Egmond, Marjolein
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7954609/
https://ncbi.nlm.nih.gov/pubmed/33561014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI134680
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars